Results



About the Author(s)



Asmaa M. Zahran  
Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt


Hanaa Nafady-Hego  
Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt


Sawsan M. Moeen  
Department of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt


Hanan A. Eltyb  
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt


Mohammed M. Wahman  
Department of Clinical Oncology, South Valley University, Qena, Egypt


Asmaa Nafady   
Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt


Citation


 Zahran AM, Nafady-Hego H, Moeen SM, Eltyb HA, Wahman MM, Nafady A. Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. Afr J Lab Med. 2022;11(1), a1713. https://doi.org/10.4102/ajlm.v11i1.1713

Note: DOI of original article published: https://doi.org/10.4102/ajlm.v10i1.1296.






                          
                               
                                    
                                            
                                                    

	
	

Correction



	

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker


	 Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady
Published: 25 Mar. 2022


Copyright: © 2022. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



	
In the published article, Zahran AM, Nafady-Hego H, Moeen SM, Eltyb HA, Wahman MM, Nafady A. Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. Afr J Lab Med. 2021;10(1), a1296. https://doi.org/10.4102/ajlm.v10i1.1296, there was an error on page 3 under the ‘Results’ section. The mean age of the MM patients should be 63.5 as per Table 1 instead of 6.35. The first paragraph under the ‘Results’ section is updated to:


Results


Baseline characteristics of newly diagnosed multiple myeloma patients and healthy controls

The mean age of the MM patients was 63.5 ± 4.07 years, and the number of men (13) was double that of women (7) (Table 1). The proportion of plasma cells in bone marrow was 39.7% ± 3.7% and that of the monoclonal band (M-protein) was 4.44 g/dL ± 2.8 g/dL.

The authors apologise for this error. The correction does not change the study’s findings of significance or overall interpretation of the study’s results or the scientific conclusions of the article in any way.